Allozymes is a biotech company that accelerating enzyme evolution for the sustainable future of industries
Allozymes has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in August 2023.
Allozymes's investors include Entrepreneurs First, SOSV, Seventure Partners, Xora Innovation, Transpose Platform Management.
Allozymes is headquartered in Singapore, Singapore.
Allozymes is a biotech company that accelerating enzyme evolution for the sustainable future of industries
Allozymes is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Allozymes — Funding & Investors." VCBacked, August 7, 2023, https://www.vcbacked.co/company/allozymes. Accessed July 19, 2026.
VCBacked. (2023). Allozymes — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/allozymes
{{cite web |title=Allozymes — Funding & Investors |url=https://www.vcbacked.co/company/allozymes |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated